@newsramp.comSS Innovations (NASDAQ: SSII) has submitted its FDA response for the SSi Mantra surgical robotic system, with clearance expected in Q1 2027. The system has been validated in 190+ procedure types in India. #SurgicalRobotics #MedTech
@robotcurrent.bsky.socialSurgiCLAW is a new hierarchical framework for precision surgical robotics that uses a multimodal LLM for visual reasoning and skill selection while delegating execution to verifiable deterministic controllers, targeting…
#Robotics #AI #SurgicalRobotics
https://arxiv.org/abs/2610.15766
@newsramp.comSS Innovations (NASDAQ: SSII) submitted its FDA response for the SSi Mantra surgical robotic system on Oct. 5, 2026, including clinical validation data. FDA review expected to conclude in Q1 2027, paving the way for U.S. market entry. #MedTech #SurgicalRobotics
@newsramp.comSS Innovations (NASDAQ: SSII) reports a 143% surge in robotic procedures and 39% revenue growth in Q2 2026, with 224 systems across 12 countries and FDA review expected by Q1 2027. #SurgicalRobotics #MedTech
@scalanovahealth.bsky.social• Deploy in <30 days with Zero-PHI wedge
• Slash R&D burn rates by 40-60%
• Retain 100% IP & entity sovereignty
• 3-phase clinical alignment, sandbox stress-testing & US FDA, CE, CDSCO regulatory pipelines.
@mengli512.bsky.socialIs Procept Bio Robotics stock a sustainable long-term investment, or does the recent price decline signal deeper financial trouble?
#PROCEPT #robot #urologicalhealth #surgicalrobotics $PRCT $OUST $TSLA
@scalanovahealth.bsky.social• 30-day zero-PHI pod deployment
• 40-60% R&D burn rate reduction
• 40-60% faster regulatory submissions
• 100% IP sovereignty & BOT transfer
Accelerate MedTech innovation with surgeon governance.
#SurgicalRobotics #MedTech #Robotics
@yinqihuang.bsky.social@gonelight.bsky.social will be presenting our work "An Adaptive LQG Model of Human Learning in Surgical Robot Teleoperation" at the #IROS2026 SurgTwin Workshop! If you’re attending the workshop, please drop by our poster and say hello! We’d love to chat!
@scalanovahealth.bsky.social1️⃣ Zero-PHI Ingestion (<30 day deploy)
2️⃣ Clinical Sandbox (Practitioner tested)
3️⃣ FDA/CE/CDSCO Submissions
✅ 40-60% R&D Burn Reduction
✅ 100% IP Sovereignty
✅ ISO 13485 Compliant
@newsramp.comSS Innovations International (NASDAQ: SSII) posted Q2 revenue of $13.9M, up 39.4% year over year, with 224 surgical robotic systems now installed across 12 countries and 12,000+ procedures completed. U.S. and EU regulatory approvals could be next. #SurgicalRobotics #MedTech
